IL6 and Cachexia: Application of an anti-IL-6 antibody to an experimental tumor-bearing mouse model suppressed IL-6 secretion in the brain, which was accompanied by an attenuation of cachexia and hyperactivity in the area postrema network and prolonged the life of the mice [32].